Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status.

Gynecologic oncology - 1 Jan 2016

Kotsopoulos Joanne, Rosen Barry, Fan Isabel, Moody Joel, McLaughlin John R, Risch Harvey, May Taymaa, Sun Ping, Narod Steven A

Abstract excerpt

OBJECTIVES: After a diagnosis of ovarian cancer, positive BRCA mutation status confers a transient mortality benefit that diminishes with time. The majority of women who survive for 10-12 years are effectively cured of their disease. Thus, it is important to estimate the probability of long-term survival by BRCA mutation status and treatment-related factors. METHODS: We included unselected epithelial ovarian...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Ovarian Epithelial
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Neoplasm Staging

Share to Neoplasms, Glandular and Epithelial

Share to Ontario

Share to Ovarian Neoplasms

Share to Survival Rate

Source

Identifiers

PMID: 26556769
DOI: 10.1016/j.ygyno.2015.11.009

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status.PMID 26556769Read ↗

Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2.Semantic proximity Read ↗

Germline Mutation in <i>BRCA1</i> or <i>BRCA2</i> and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian CancerSemantic proximity Read ↗

Estimating survival rates after ovarian cancer among women tested for BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer.Semantic proximity Read ↗

Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?Semantic proximity Read ↗

Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer.Semantic proximity Read ↗

Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.Semantic proximity Read ↗

Improved survival in BRCA2 carriers with ovarian cancer.Semantic proximity Read ↗

Breast cancer survival in Nordic BRCA2 mutation carriers-unconventional association with oestrogen receptor status.Semantic proximity Read ↗

Failure of BRCA1 dysfunction to alter ovarian cancer survival.Semantic proximity Read ↗

Do BRCA1 and BRCA2 mutation carriers have earlier natural menopause than their noncarrier relatives? Results from the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer.Semantic proximity Read ↗

Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.